Kalisch Ellett, Lisa M. http://orcid.org/0000-0001-5063-6128
Dorj, Gerel http://orcid.org/0000-0001-9489-6829
Andrade, Andre Q. http://orcid.org/0000-0001-6587-3169
Bilton, Rebecca L. http://orcid.org/0000-0003-1932-8957
Rowett, Debra http://orcid.org/0000-0002-8977-0401
Whitehouse, Joseph
Lim, Renly http://orcid.org/0000-0003-4135-2523
Pratt, Nicole L.
Kelly, Thu-Lan http://orcid.org/0000-0002-7691-9289
Parameswaran Nair, Nibu http://orcid.org/0000-0002-0202-6453
Bereznicki, Luke http://orcid.org/0000-0003-3974-3437
Widagdo, Imaina http://orcid.org/0000-0002-0669-0183
Roughead, Elizabeth E. http://orcid.org/0000-0002-6811-8991
Funding for this research was provided by:
Department of Health and Aged Care, Australian Government
University of South Australia
Article History
Accepted: 20 March 2023
First Online: 19 April 2023
Declarations
:
: This work was supported by the Australian Government Department of Health Pharmacy Trial Program.
: RB was employed as the ReMInDAR partnership engagement and trial manager to oversee the operations management for the trial. The authors have no other competing interests
: Ethics approval to conduct the study was received from the University of South Australia Human Research Ethics committee (ID: 0000036440) and the Tasmania Health and Medical Human Research Ethics Committee, University of Tasmania (ID: H0017022).
: The trial adopted an “opt out approach”, as requested by the residential aged-care facilities and consumer advisors and approved by the ethics committees. In compliance with the National Statement of Ethical Conduct in Human Research section 2.3.6, flyers were displayed at all participating residential aged-care facilities at least one month prior to recruitment to inform the residents, family members and staff of the introduction of the pharmacist service. In addition, flyers were provided to all potential residents. The flyer explained the pharmacist service, information on what to do if the residents did not wish to participate and informed the residents that they could opt out at any time throughout the study period. The trial excluded persons with moderate or severe dementia, as determined by the last facility recorded Psychogeriatric Assessment scale (PAS) or through administration of the Montreal Cognitive assessment (MoCA) tool during eligibility screening, meaning that the eligible residents had the capacity to decline participation if they wished to do so. Participants who enrolled in the trial could withdraw from the trial for any reason or without having to give reasons.
: Not applicable as all data available to the study team were anonymous.
: The datasets generated during and/or analysed during the current study are available from the data custodian by request.
: Not applicable
: LKE: study design, data analysis and interpretation, writing of the manuscript. GD, AAQ, RLB, DR, JW: study design, data analysis and interpretation, review of the manuscript for important intellectual content. RL, NLP, TLK, NNP, LB, EER: study design, review of the manuscript for important intellectual content. All authors read and approved the final version.